Search

Displaying results 6611 - 6620 of 10000 in total
  1. Drug

    TG-C

    go.drugbank.com/drugs/DB06004
    Investigational

  2. Drug

    MB07811

    go.drugbank.com/drugs/DB05192
    Investigational

    MB07811 is the first of a novel class of product candidates discovered by Metabasis designed to lower serum cholesterol and triglycerides. … MB07811, a small molecule that is administered orally, has been extensively studied preclinically and is currently undergoing clinical testing.

  3. Drug

    Abafungin

    go.drugbank.com/drugs/DB06395
    Experimental

  4. Drug

    BG1805

    go.drugbank.com/drugs/DB18667
    Investigational

    BG1805 is an investigational anti-CLL1 chimeric antigen receptor (CAR) T-cell therapy.

  5. Drug

    RPI-MN

    go.drugbank.com/drugs/DB17957
    Experimental

    [A260132] Being developed by Nutra Pharma under the trade name PEPTERON, it is being investigated for the treatment of neurological and immune disorders.[L47107] … RPI-MN is a detoxified or chemically modified alpha-cobratoxin with antiviral properties.

    Synonyms: RPI-MN
  6. Drug

    Anethole

    go.drugbank.com/drugs/DB15916
    ApprovedWithdrawn

    Categories: Diet, Food, and Nutrition, Compounds used in a research, industrial, or household setting
  7. Drug

    Ethanolamine

    go.drugbank.com/drugs/DB03994
    Investigational

    A viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. … It is used as a surfactant, fluorimetric reagent, and to remove CO2 and H2S from natural gas and other gases.

  8. Drug

    Melengestrol

    go.drugbank.com/drugs/DB11529
    ExperimentalVet approved

    Melengestrol is a steroidal progestin and antineoplastic agent which was never marketed. An acylated derivative, melengestrol acetate, is used as a growth promoter in animals.

    Categories: Hormones, Hormone Substitutes, and Hormone Antagonists
  9. Drug

    Mesmulogene ancovacivec

    go.drugbank.com/drugs/DB06584
    Investigational

    resulting in tumor cell lysis. … A bivalent cancer vaccine comprised of a modified vaccinia virus Ankara (MVA) strain encoding human mucin 1 (MUC1) and interleukin-2 (IL-2) with potential immunostimulating and antineoplastic activities

    Categories: Amino Acids, Peptides, and Proteins
  10. Drug

    Isaralgagene civaparvovec

    go.drugbank.com/drugs/DB16808
    Investigational

    It is developed by Sangamo Therapeutics and investigated in Fabry Disease. … Isaralgagene civaparvovec, formerly known as ST-920, is liver-tropic rAAV 2/6 vector carrying the cDNA for human alpha-galactosidase A (α-Gal A) enzyme.